US Bancorp’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-265
| Closed | -$25K | – | 4284 |
|
|
2021
Q4 | $25K | Buy |
265
+111
| +72% | +$7.31K | ﹤0.01% | 3003 |
|
|
2021
Q3 | $9K | Buy |
154
+37
| +32% | +$2.19K | ﹤0.01% | 3507 |
|
|
2021
Q2 | $8K | Sell |
117
-205
| -64% | -$13.4K | ﹤0.01% | 3506 |
|
|
2021
Q1 | $22K | Buy |
322
+69
| +27% | +$5.31K | ﹤0.01% | 2992 |
|
|
2020
Q4 | $19K | Buy |
253
+125
| +98% | +$9.37K | ﹤0.01% | 2950 |
|
|
2020
Q3 | $10K | Sell |
128
-25
| -16% | -$1.67K | ﹤0.01% | 3102 |
|
|
2020
Q2 | $10K | Buy |
153
+104
| +212% | +$5.72K | ﹤0.01% | 3116 |
|
|
2020
Q1 | $2K | Hold |
49
| – | – | ﹤0.01% | 3511 |
|
|
2019
Q4 | $2K | Sell |
49
-165
| -77% | -$7.8K | ﹤0.01% | 3519 |
|
|
2019
Q3 | $10K | Buy |
214
+190
| +792% | +$10.7K | ﹤0.01% | 3065 |
|
|
2019
Q2 | $1K | Hold |
24
| – | – | ﹤0.01% | 3587 |
|
|
2019
Q1 | $1K | Hold |
24
| – | – | ﹤0.01% | 3549 |
|
|
2018
Q4 | $1K | Hold |
24
| – | – | ﹤0.01% | 3549 |
|
|
2018
Q3 | $1K | Hold |
24
| – | – | ﹤0.01% | 3600 |
|
|
2018
Q2 | $1K | Sell |
24
-325
| -93% | -$14K | ﹤0.01% | 3583 |
|
|
2018
Q1 | $14K | Sell |
349
-86
| -20% | -$3.35K | ﹤0.01% | 3066 |
|
|
2017
Q4 | $15K | Sell |
435
-571
| -57% | -$16.3K | ﹤0.01% | 3023 |
|
|
2017
Q3 | $25K | Buy |
+1,006
| New | +$23.1K | ﹤0.01% | 2813 |
|
|
2014
Q2 | – | Sell |
-630
| Closed | -$40K | – | 3578 |
|
|
2014
Q1 | $40K | Hold |
630
| – | – | ﹤0.01% | 2575 |
|
|
2013
Q4 | $37K | Buy |
+630
| New | +$32.9K | ﹤0.01% | 2551 |
|
|
2013
Q3 | – | Sell |
-286
| Closed | -$22K | – | 3361 |
|
|
2013
Q2 | $22K | Buy |
+286
| New | +$23.3K | ﹤0.01% | 2625 |
|
US Bancorp's ARNA Position: Q1 2022 in Review
US Bancorp sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 265 shares — an estimated $25K sold.
US Bancorp first reported a position in ARNA in Q2 2013 and held it in 21 quarters. The position peaked at $40K in Q1 2014. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- US Bancorp reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- US Bancorp sold 265 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $25K.
- US Bancorp first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 21 quarters.
- US Bancorp's Arena Pharmaceuticals Inc position peaked at $40K in Q1 2014.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on US Bancorp's 13F filing for Q1 2022, filed 11 May 2022.